Pulmonary delivery for levodopa

Details for Australian Patent Application No. 2003218307 (hide)

Owner Advanced Inhalation Research, Inc.

Inventors Emerich, Dwaine F; Bennett, David J; Bartus, Raymond T; Ja;ckson, Blair

Agent Davies Collison Cave

Pub. Number AU-B-2003218307

PCT Number PCT/US03/08659

PCT Pub. Number WO2003/079992

Priority 60/366,471 20.03.02 US

Filing date 19 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 27 July 2006

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/366,471 20.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003218307

27 July 2006 Application Accepted

  Published as AU-B-2003218307

31 August 2006 Corrigenda

  Applications Accepted - Name Index Under the name Advanced Inhalation Research, Inc., Application No. 2003218307, under INID (72), amend the co-inventor to Jackson, Blair.

23 November 2006 Standard Patent Sealed

28 August 2008 Assignment Registered

  Advanced Inhalation Research, Inc. The patent has been assigned to Alkermes, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218308-hGH (humam growth hormone) formulations for pulmonary administration

2003218306-Method for administration of growth hormone via pulmonary delivery